These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2883249)

  • 1. The relationship of thyroid antibodies to the postpartum recurrence of hyperthyroidism in Graves' disease.
    Chang TC; Chen FW; Tsai WY; Chen SH; Chang CC; Yu TK; Chen YP; Liaw KY
    Taiwan Yi Xue Hui Za Zhi; 1987 Feb; 86(2):171-7. PubMed ID: 2883249
    [No Abstract]   [Full Text] [Related]  

  • 2. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves' disease.
    Hashizume K; Ichikawa K; Nishii Y; Kobayashi M; Sakurai A; Miyamoto T; Suzuki S; Takeda T
    J Clin Endocrinol Metab; 1992 Jul; 75(1):6-10. PubMed ID: 1642700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid-stimulating hormone receptor antibodies--the calm after the storm after the calm?
    Davies TF
    Mayo Clin Proc; 1988 Jul; 63(7):736-9. PubMed ID: 2898573
    [No Abstract]   [Full Text] [Related]  

  • 5. Postpartum recurrence of hyperthyroidism and changes of thyroid-stimulating immunoglobulins in Graves' disease.
    Yabu Y; Amino N; Mori H; Miyai K; Tanizawa O; Takai SI; Kumahara Y; Matsuzuka F; Kuma K
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1454-8. PubMed ID: 6108332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of measuring thyroid receptor antibodies, thyroid-stimulating and thyroid stimulation-blocking antibodies.
    Sasaki N; Tamaru K; Tsuyusaki T; Inomata H; Niimi H; Nakajima H
    Acta Paediatr Jpn; 1988; 30 Suppl():133-8. PubMed ID: 2906202
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thyrotropin-binding inhibitory immunoglobulins G in thyroid gland cells in patients with Graves-Basedow disease. Clinical studies].
    Nauman J; Faryna M; Kwiatkowska-Dutkiewicz E; Roszkowska K
    Endokrynol Pol; 1986; 37(4):143-52. PubMed ID: 2881778
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoimmune thyroid disease.
    Bottazzo GF; Doniach D
    Annu Rev Med; 1986; 37():353-9. PubMed ID: 2871804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG heavy-chain subclass restriction of thyrotropin-binding inhibitory immunoglobulins in Graves' disease.
    Weetman AP; Byfield PG; Black C; Reimer CB
    Eur J Clin Invest; 1990 Aug; 20(4):406-10. PubMed ID: 1977589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thyrotropin-binding inhibitory immunoglobulins G in thyroid gland cells in patients with Graves-Basedow disease. II. Various methodologic aspects of their analysis].
    Faryna M
    Endokrynol Pol; 1986; 37(4):153-61. PubMed ID: 2881779
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term effect of radioiodine therapy on the thyroid antibodies in the patients of Graves' disease with postirradiation hypothyroidism.
    Chang TC; Chang CC; Chen FW; Liaw KY
    Taiwan Yi Xue Hui Za Zhi; 1986 Dec; 85(12):1177-82. PubMed ID: 2880926
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thyroid-stimulating immunoglobulins. The related antigens].
    Pinchera A; Fenzi GF; Macchia E; Vitti P; Monzani F; Kohn LD
    Ann Endocrinol (Paris); 1982 Dec; 43(6):520-33. PubMed ID: 6134493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W; Man N; Li YS; Shan ZY; Teng WP
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
    Kung AW; Lau KS; Kohn LD
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between thyroid microsomal antibodies of subclass IgG-1 and hypothyroidism in autoimmune postpartum thyroiditis.
    Jansson R; Thompson PM; Clark F; McLachlan SM
    Clin Exp Immunol; 1986 Jan; 63(1):80-6. PubMed ID: 3754185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies.
    Ilicki A; Gamstedt A; Karlsson FA
    J Clin Endocrinol Metab; 1992 May; 74(5):1090-4. PubMed ID: 1349025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity of thyroid disease. With emphasis on Graves' disease.
    van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G
    Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease.
    O'Donnell J; Trokoudes K; Silverberg J; Row V; Volpé R
    J Clin Endocrinol Metab; 1978 May; 46(5):770-7. PubMed ID: 233633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graves' hyperthyroidism following primary hypothyroidism: sequential changes in various activities of thyrotropin receptor antibodies.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK
    Acta Endocrinol (Copenh); 1989 Apr; 120(4):447-50. PubMed ID: 2566247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.